 CAMBRIDGE, Mass., Feb. 19, 2021 GLOBE NEWSWIRE -- Constellation Pharmaceuticals, Inc. Nasdaq: CNST, a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that the Company will participate in an upcoming virtual investor conference. Jigar Raythatha, CEO, will present at the 10th Annual SVB Leerink Global Healthcare Conference at 3:40 PM EDT on February 26. Live audio webcast of Mr. Raythathas presentations and archives for replay will be available on the Investor Relations section of Constellations website at The audio webcast replays will be available for 90 days following the live presentation. 